India–Oman CEPA to Come Into Force in 3 Months — A Major Boost for Trade & Pharma

Duty-free access & faster pharma approvals The India–Oman Comprehensive Economic Partnership Agreement (CEPA) — signed on 18 December 2025 — is expected to become operational within the next three months, marking a fast-tracked implementation compared to earlier free trade deals. Under this pact, India will gain near-universal duty-free access on about 98% of its exports to Oman, while both countries work to fast-track approvals for Indian pharmaceutical products and manufacturers recognised by global regulators like the USFDA, EMA, and UKMHRA. Sectors Likely to Benefit Pharmaceuticals & Healthcare – With fast-track approvals and duty-free access. Textiles & Apparel – Lower tariffs strengthen price competitiveness. Gems, Jewellery & Leather – MSME-heavy sectors gain from expanded exports. Engineering Goods & Auto Components – Enhanced access to Gulf markets under the CEPA framework Indian Listed Stocks to Watch Here are 4 Indian listed companies that could benefit from stronger India–Oman economic ties and expanded export opportunities:

d – India’s major pharma exporter likely to benefit from faster approvals and tariff reductions. Dr. Reddy’s Laboratories Ltd – Strong global regulatory footprint positions it well for CEPA-related market access. Ltd – A leading textiles & apparel company that could gain from duty-free market entry. Company Ltd – A key player in gems & jewellery, positioned to capitalize on tariff-free exports.